SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI
CCSI 28.67-2.5%3:58 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: max who wrote (1668)4/4/1998 1:15:00 PM
From: JanyBlueEyes   of 5736
 
Third-Party Reimbursement Info

From the Annual Report (10K) Filed on March 30,1998

In the United States, patients, hospitals and physicians who purchase medical devices, generally rely on third-party payors, principally federal Medicare, state Medicaid and private health insurance plans, to reimburse them for all or a portion of the cost of the medical device. Reimbursement for devices that have received FDA clearance has generally been available in the United States.

The Company has obtained confirmation from the Department of Coding of the American Medical Association ("AMA") that the same code used for the reimbursement of laboratory blood tests used to monitor bilirubin infant jaundice is permissible for use in obtaining reimbursement for tests using the Colormate(TM) Bilirubin Device.

The Company believes this confirmation will be an important factor in its pricing structure in the United States.......
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext